← Back to all signals
RESEARCH PAPER ANALYSIS

Changes in Body Weight Percentile During Primary Anticancer Treatment in Children: A Retrospective Single-Center Study.

AI interpretation is pending for this paper.

Open original publication →
PMID42948697
JournalCureus
Publication Date2026-09-27
Ingested2026-10-29 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Objective Body weight trajectories may change during anticancer treatment in children. This study aimed to evaluate changes in body weight percentile categories during primary anticancer treatment in pediatric oncology patients and to assess whether the magnitude and direction of these changes were associated with baseline body weight percentile category. Materials and methods This retrospective single-center study included 138 children diagnosed and treated for malignant disease between 2021 and 2025. Body weight was assessed at the initiation and at the completion of primary anticancer treatment using World Health Organization growth standards for children aged 0 to five years and Polish OLAF reference charts for children and adolescents aged six to 17 years. Each measurement was assigned to one of eight predefined centile channels, and continuous analyses were performed on the midpoints of these channels rather than on exact individual percentile values. Body weight percentile categories were analyzed, and changes between baseline and treatment completion were evaluated using the Wilcoxon signed-rank test and the Kruskal-Wallis test. Results Complete paired anthropometric data were available for 138 patients. The mean body weight percentile (channel midpoint) decreased from 56.1 at treatment initiation to 54.65 at treatment completion, while the median remained 62.5 at both assessments. The difference was not statistically significant (p = 0.5254). The proportion of children below the 10th percentile increased from 10.14% to 13.04%, whereas the proportion above the 90th percentile decreased from 22.46% to 16.67%. Most patients remained within the same percentile category or changed by only one category. Baseline body weight percentile category was significantly associated with the distribution of category-change scores (H = 15.25, p = 0.033, η² = 0.06). Children with lower baseline percentiles tended to shift upward, whereas those with higher baseline percentiles tended to shift downward; this pattern should be interpreted with caution, as it may partly reflect regression to the mean and the structurally restricted range of possible change in the extreme categories, in which upward or downward shifts are arithmetically limited. Conclusions Body weight percentiles showed no statistically significant overall change at the population level during primary anticancer treatment; however, individual changes in percentile categories were common. Regular assessment of body weight percentile trajectories may identify changes that are not apparent from group-level measures and may prompt further nutritional assessment. Body weight percentile alone does not provide a comprehensive assessment of nutritional status.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 [Nontuberculous mycobacterial infections in patients with hematologic diseases]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64.4 2 [Fundamentals of genetic counseling in hematology: pedigree construction and management of secondary findings in HemeSight®]. [Rinsho ketsueki] The Japanese journal of clinical hematology 49.9 3 Uncovering LINC02982: a T-ALL-specific lncrna linking epigenetic regulation and metabolic pathways. Cancer cell international 51.9 4 Knowledge and awareness of oral cancer and precancerous lesions among patients attending Dhaka Dental College Hospital: a cross-sectional study. BMC oral health 66.4 5 Erratum: Addition of Rituximab to First-Line Treatment of Burkitt Lymphoma in Children and Young Adults in Tanzania: A Cost-Utility Analysis. JCO global oncology 50.74 6 Subclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib. American journal of clinical pathology 62.42 7 Trachea, bronchus, and lung cancer in women of reproductive age: global burden trends from 1990 to 2021 and forecasts to 2035. Frontiers in global women's health 38.5 8 From missed diagnosis to lifelong survivorship: a precision oncology roadmap for equity in pediatric and AYA cancer care. Frontiers in oncology 61.8 9 Genomic rearrangements define a distinct biological state in neuroblastoma. Cancer genetics 57.2 10 Clinical characteristics and treatment outcomes of neuroblastoma with pulmonary metastases. World journal of pediatric surgery 71.44 11 A rare cause of dysphagia: A case report on gastroesophageal adenocarcinoma in childhood. JPGN reports 51.9 12 Patterns of high-risk histopathology features of retinoblastoma in enucleated and exenterated eyes at Tikur Anbessa Specialized Hospital: a retrospective study. Cancer treatment and research communications 67.9 13 Pediatric cancer and ethical decision-making: Who speaks for the child? Journal of pediatric nursing 65.3 14 Diagnostic evaluation of long-read nanopore sequencing for pediatric CNS tumors. Acta neuropathologica communications 57.5 15 Preventive Immunomodulatory Effects of Doxycycline and Hyperbaric Oxygen Therapy on Serum Tumor Necrosis Factor-α and Interleukin-6 Levels in a Rat Model of Malaria. Journal of parasitology research 58.44 16 Persistent Pediatric Cervical Lymphadenopathy: A Case Report of Kikuchi-Fujimoto Disease Mimicking Infection and Malignancy. Case reports in pediatrics 50.2 17 Cementoblastoma With Bony and Soft Tissue Recurrences Following a Primary Molar Lesion: A Case Report. Case reports in dentistry 47.5 18 Global, Regional, and National Trends of Pediatric Soft Tissue and Other Extraosseous Sarcomas, 1990 to 2021: A GBD Study. Journal of pediatric hematology/oncology 60.4 19 Breaking the Barrier: MBI-LCBI and Recent Beta-lactam Exposure as Predictors of Piperacillin-Tazobactam Resistance in Pediatric Hemato-oncology Patients. The Pediatric infectious disease journal 69.4 20 Exploiting iron metabolism in Ewing sarcoma. Communications medicine 64.2 21 Unusual [18F]FDOPA PET-CT maging of insulinomas in children. EJNMMI reports 53.0 22 Spontaneous inversion of the left atrial appendage: a first autopsy case report and updated literature review. Cardiology in the young 45.5 23 Prognostic significance of end-of-induction measurable residual disease below 0.01% in pediatric B-lineage acute lymphoblastic leukemia. Cytometry. Part B, Clinical cytometry 65.8 24 Multiple Exposures to Antibiotics Affect Tumor Development in a Mouse Model of Early-Onset Colorectal Cancer. Carcinogenesis 50.9 25 Population-Based Assessment of Cardiometabolic Late Effects in 5-Year Survivors of Pediatric Acute Lymphoblastic Leukemia. Pediatric blood & cancer 69.2 26 Circulating Biomarkers of Disease Burden in Patients With Relapsed or Refractory Neuroblastoma Treated With 131I-MIBG Therapy: A Report From the New Approaches to Neuroblastoma Therapy Consortium. Pediatric blood & cancer 85.43 27 Venetoclax as Salvage Treatment for Relapsed/Refractory B-ALL Post-CAR-T Therapy. Pediatric blood & cancer 82.0 28 Surgical Margin and Risk of Local Recurrence in Children and Young Adults With Nonrhabdomyosarcoma Soft Tissue Sarcoma: A Nonrandomized Clinical Trial. JAMA surgery 86.8 29 Enzyme-functionalized β-cyclodextrin silicasomes for sequential stroma remodeling and combination chemotherapy in neuroblastoma. Journal of materials chemistry. B 61.64 30 Undescended Testes in Medically Complex Children: Evaluating A Common Urologic Condition Through a Multi-Disciplinary Lens. The Journal of urology 59.5 31 Brain-sensing synNotch-CAR T cells enable precise targeting and clearance of diffuse midline glioma in multiple preclinical models. Science translational medicine 66.0 32 Research priority setting in childhood cancer: An integrative review. Journal of child health care : for professionals working with children in the hospital and community 59.0
PATIENT-FRIENDLY SUMMARY

Changes in Body Weight Percentile During Primary Anticancer Treatment in Children: A Retrospective Single-Center Study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic